Product Images Pregabalin

This appears to be a calculation for estimating an individual's creatinine clearance (CLCT) using their age, weight, and serum creatinine level. However, the text is not complete and contains many errors in the form of non-English characters and unclear symbols. Further information is needed to provide a more detailed description.*

This appears to be a chart showing the percentage of subjects without LTR (unknown definition) for a medication called Progabain and a placebo, over a period of 120 to 180 days. Not much context is given, so it's unclear what the overall purpose of the study or chart is.*

The text describes a chart showing the percentage of subjects who experienced improvement over a period of 16 weeks, using both pregabalin and placebo. The chart displays percentage values between 100 and 280, separated by increments of 10.*

The text describes a chart or table indicating the percentage of patients who have improved along with a medication regimen of Pregabalin 160mg for three days. It also shows the percentage improvement in pain from baseline. However, there is some random text which is not decipherable.*

This appears to be a record of a medical study comparing the effectiveness of three different treatments for pain. The treatments were Fregabalin (100 mg, three times per day), Pregataiin (80 mg, three times per day), and a placebo. The table shows the percentage of patients who improved with each treatment, and the percentage improvement in pain from baseline.*

This appears to be a table or chart with some information about different studies, doses of medication (ranging from placebo to 600mg/day), and some indication that certain treatments were statistically significant compared to placebo. However, without more context or a clear understanding of what the table is trying to convey, it is difficult to provide a more specific or useful description.*

The text shows a graph measuring the percentage of patients improved using different doses of pregabalin (300mg and 450mg) compared to a placebo. The improvement is measured in pain reduction from a baseline measurement. The graph shows that the higher dose of pregabalin had a greater percentage of patient improvement than the lower dose and the placebo.*

This is a description of a medication named Pregabalin 200mg capsule, which comes in a quantity of 30. It is being compared to a drug called Lyrica. It also includes the NDC code, the source NDC code, and an expiration date of 8/31/2023. The rest of the text seems to be unrelated characters and is not available for understanding.*

This is a medication package for Pregabalin 200mg capsules that contains 60 capsules with a specific lot number and expiration date. The NDC and source NOC numbers are also provided for tracking purposes. The text "AIMHNHAARRED" followed by "<~" appears randomly and does not provide any relevant information.*

This is a medicine label for PREGABALIN 200MG CAPSULE. It contains information on the lot number, expiration date, and source NDC code. The recommended storage temperature is 20°C to 25°C. It is unclear what "Advanced % ST" and "S/ 0000001 38008" refer to.*